Lanean...
Incorporating VEGF-targeted therapy in advanced urothelial cancer
Patients with relapsed or refractory urothelial carcinoma (UC) have poor prognosis coupled with few options for systemic treatment. The role of angiogenesis in the evolution of cancers has been established, and studies have shown that it plays a key role in the pathogenesis of UC. Many targeted agen...
Gorde:
| Argitaratua izan da: | Ther Adv Med Oncol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5298449/ https://ncbi.nlm.nih.gov/pubmed/28203296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834016667179 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|